These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 25393311)

  • 21. Men's and women's response to treatment and perceptions of outcomes in a randomized controlled trial of injectable opioid assisted treatment for severe opioid use disorder.
    Palis H; Marchand K; Guh D; Brissette S; Lock K; MacDonald S; Harrison S; Anis AH; Krausz M; Marsh DC; Schechter MT; Oviedo-Joekes E
    Subst Abuse Treat Prev Policy; 2017 May; 12(1):25. PubMed ID: 28526048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gender-specific predictors of retention and opioid abstinence during methadone maintenance treatment.
    Levine AR; Lundahl LH; Ledgerwood DM; Lisieski M; Rhodes GL; Greenwald MK
    J Subst Abuse Treat; 2015 Jul; 54():37-43. PubMed ID: 25795601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of characteristics and outcomes of opioid-dependent patients initiating office-based buprenorphine or methadone maintenance treatment.
    Fingerhood MI; King VL; Brooner RK; Rastegar DA
    Subst Abus; 2014; 35(2):122-6. PubMed ID: 24821346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methadone medical maintenance in primary care. An implementation evaluation.
    Merrill JO; Jackson TR; Schulman BA; Saxon AJ; Awan A; Kapitan S; Carney M; Brumback LC; Donovan D
    J Gen Intern Med; 2005 Apr; 20(4):344-9. PubMed ID: 15857492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Buprenorphine retention in primary care.
    Stein MD; Cioe P; Friedmann PD
    J Gen Intern Med; 2005 Nov; 20(11):1038-41. PubMed ID: 16307630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparing adaptive stepped care and monetary-based voucher interventions for opioid dependence.
    Brooner RK; Kidorf MS; King VL; Stoller KB; Neufeld KJ; Kolodner K
    Drug Alcohol Depend; 2007 May; 88 Suppl 2(Suppl 2):S14-23. PubMed ID: 17257782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decrease in self-reported offences and incarceration rates during methadone treatment: A comparison between patients switching from buprenorphine to methadone and maintenance treatment incident users (ANRS-Methaville trial).
    Carrieri P; Vilotitch A; Nordmann S; Lions C; Michel L; Mora M; Morel A; Maradan G; Spire B; Roux P;
    Int J Drug Policy; 2017 Jan; 39():86-91. PubMed ID: 27770695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A 12-month controlled trial of methadone medical maintenance integrated into an adaptive treatment model.
    King VL; Kidorf MS; Stoller KB; Schwartz R; Kolodner K; Brooner RK
    J Subst Abuse Treat; 2006 Dec; 31(4):385-93. PubMed ID: 17084792
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparing retention in treatment and mortality in people after initial entry to methadone and buprenorphine treatment.
    Bell J; Trinh L; Butler B; Randall D; Rubin G
    Addiction; 2009 Jul; 104(7):1193-200. PubMed ID: 19563562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The practice of office-based buprenorphine treatment of opioid dependence: is it associated with new patients entering into treatment?
    Sullivan LE; Chawarski M; O'Connor PG; Schottenfeld RS; Fiellin DA
    Drug Alcohol Depend; 2005 Jul; 79(1):113-6. PubMed ID: 15943950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Opioid addicted buprenorphine injectors: drug use during and after 12-weeks of buprenorphine-naloxone or methadone in the Republic of Georgia.
    Piralishvili G; Otiashvili D; Sikharulidze Z; Kamkamidze G; Poole S; Woody GE
    J Subst Abuse Treat; 2015 Mar; 50():32-7. PubMed ID: 25456093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of maintenance treatment with methadone for opioid dependence: a meta-analytical study.
    Johansson BA; Berglund M; Lindgren A
    Nord J Psychiatry; 2007; 61(4):288-95. PubMed ID: 17763122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Feasibility and outcome of substitution treatment of heroin-dependent patients in specialized substitution centers and primary care facilities in Germany: a naturalistic study in 2694 patients.
    Wittchen HU; Apelt SM; Soyka M; Gastpar M; Backmund M; Gölz J; Kraus MR; Tretter F; Schäfer M; Siegert J; Scherbaum N; Rehm J; Bühringer G
    Drug Alcohol Depend; 2008 Jun; 95(3):245-57. PubMed ID: 18337025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of outcome in LAAM, buprenorphine, and methadone treatment for opioid dependence.
    Marsch LA; Stephens MA; Mudric T; Strain EC; Bigelow GE; Johnson RE
    Exp Clin Psychopharmacol; 2005 Nov; 13(4):293-302. PubMed ID: 16366759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A naturalistic comparison of the effectiveness of methadone and two sublingual formulations of buprenorphine on maintenance treatment outcomes: findings from a retrospective multisite study.
    Proctor SL; Copeland AL; Kopak AM; Herschman PL; Polukhina N
    Exp Clin Psychopharmacol; 2014 Oct; 22(5):424-33. PubMed ID: 25069011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retention rate and substance use in methadone and buprenorphine maintenance therapy and predictors of outcome: results from a randomized study.
    Soyka M; Zingg C; Koller G; Kuefner H
    Int J Neuropsychopharmacol; 2008 Aug; 11(5):641-53. PubMed ID: 18205978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Controlled trial of prescribed heroin in the treatment of opioid addiction.
    March JC; Oviedo-Joekes E; Perea-Milla E; Carrasco F;
    J Subst Abuse Treat; 2006 Sep; 31(2):203-11. PubMed ID: 16919749
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Buprenorphine-based regimens and methadone for the medical management of opioid dependence: selecting the appropriate drug for treatment.
    Maremmani I; Gerra G
    Am J Addict; 2010; 19(6):557-68. PubMed ID: 20958853
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparing opium tincture and methadone for medication-assisted treatment of patients with opioid use disorder: Protocol for a multicenter parallel group noninferiority double-blind randomized controlled trial.
    Nikoo M; Moazen-Zadeh E; Nikoo N; Javidanbardan S; Kazemi A; Choi F; Vogel M; Gholami A; Tavakoli S; Givaki R; Jazani M; Mohammadian F; Markazi Moghaddam N; Goudarzi N; Schutz C; Jang K; Akhondzadeh S; Krausz M
    Int J Methods Psychiatr Res; 2019 Mar; 28(1):e1768. PubMed ID: 30714249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of Retention and Drug Use Among Patients With Opioid Use Disorder Transferred to a Specialty "Second Chance" Methadone Program.
    Moses TE; Rhodes GL; Tavakoli E; Christensen CW; Amirsadri A; Greenwald MK
    Subst Abuse; 2022; 16():11782218221138335. PubMed ID: 36407024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.